Induction of apoptosis in A549 human lung cancer cells by all-trans retinoic acid incorporated in DOTAP/cholesterol liposomes

Journal of Controlled Release

Volumn 110, Issue 3, 2006, Pages 514-521

  Kawakami, Shigeru ^a   Suzuki, Sachiko ^a   Yamashita, Fumiyoshi ^a   Hashida, Mitsuru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

All trans retinoic acid; Cationic liposomes; Drug delivery system; Non small cell lung carcinoma

Indexed keywords

CELLS; CHOLESTEROL; DRUG THERAPY; TUMORS;

ALL-TRANS RETINOIC ACID; CATIONIC LIPOSOMES; DRUG DELIVERY SYSTEMS;

CONTROLLED DRUG DELIVERY;

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; CATION; CHOLESTEROL; LIPOSOME; MESSENGER RNA; RETINOIC ACID;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CHOLESTEROL; FATTY ACIDS, MONOUNSATURATED; HUMANS; LIPOSOMES; LUNG NEOPLASMS; QUATERNARY AMMONIUM COMPOUNDS; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 31544446047     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2005.10.030     Document Type: Article

References (40)

1. A.I. Spira, and M.A. Carducci Differentiation therapy Curr. Opin. Pharmacol. 3 2003 338 343
2. M.E. Huang, Y.C. Ye, S.R. Chen, J.R. Chai, J.X. Lu, L. Zhoa, L.J. Gu, and Z.Y. Wang Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia Blood 72 1988 567 572
3. S. Castaigne, C. Chomienne, M.T. Daniel, P. Ballerini, R. Berger, P. Fenaux, and L. Degos All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia: I. Clinical results Blood 76 1990 1704 1709
4. D.G. Kim, B.H. Jo, K.R. You, and D.S. Ahn Apoptosis induced by retinoic acid in Hep3B cells in vitro Cancer Lett. 107 1996 149 159
5. K. Hayashi, H. Yokozaki, K. Naka, W. Yasui, R. Lotan, and E. Tahara Overexpression of retinoic acid receptor β induces growth arrest and apoptosis in oral cancer cells Jpn. J. Cancer Res. 92 2001 42 50
6. Y. Choi, S.Y. Kim, S.H. Kim, J. Yang, K. Park, and Y. Byun Inhibition of tumor growth by biodegradable microspheres containing all-trans-retinoic acid in a human head-and-neck cancer xenograft Int. J. Cancer 107 2003 145 148
7. Y.F. Lee, B.Y. Bao, and C. Chang Modulation of the retinoic acid-induced cell apoptosis and differentiation by the human TR4 orphan nuclear receptor Biochem. Biophys. Res. Commun. 323 2004 876 883
8. C. Di, S. Liao, D.C. Adamson, T.J. Parrett, D.K. Broderick, Q. Shi, C. Lengauer, J.M. Cummins, V.E. Velculescu, D.W. Fults, R.E. McLendon, D.D. Bigner, and H. Yan Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid Cancer Res. 65 2005 919 924
9. S.J. Freemantle, M.J. Spinella, and E. Dmitrovsky Retinoids in cancer therapy and chemoprevention: promise meets resistance Oncogene 22 2003 7305 7315
10. D. DiSepio, C. Ghosn, R.L. Eckert, A. Deucher, N. Robinson, M. Duvic, R.A. Chandraratna, and S. Nagpal Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene Proc. Natl. Acad. Sci. U. S. A. 95 1998 14811 14815
11. A. Deucher, S. Nagpal, R.A. Chandraratna, D. DiSepio, N.A. Robinson, S.R. Dashti, and R.L. Eckert The carboxy-terminal hydrophobic domain of TIG3, a class II tumor suppressor protein, is required for appropriate cellular localization and optimal biological activity Int. J. Oncol. 17 2000 1195 1203
12. E. Higuchi, R.A. Chandraratna, W.K. Hong, and R. Lotan Induction of TIG3, a putative class II tumor suppressor gene, by retinoic acid in head and neck and lung carcinoma cells and its association with suppression of the transformed phenotype Oncogene 22 2003 4627 4635
13. J. Geradts, J.Y. Chen, E.K. Russell, J.R. Yankaskas, L. Nieves, and J.D. Minna Human lung cancer cell lines exhibit resistance to retinoic acid treatment Cell Growth Differ. 4 1993 799 809
14. B.M. van der Leede, C.E. van den Brink, and P.T. van der Saag Retinoic acid receptor and retinoid X receptor expression in retinoic acid-resistant human tumor cell lines Mol. Carcinog. 8 1993 112 122
15. S.K. Manna, and B.B. Aggarwal All-trans-retinoic acid upregulates TNF receptors and potentiates TNF-induced activation of nuclear factors-κB, activated protein-1 and apoptosis in human lung cancer cells Oncogene 19 2000 2110 2119
16. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Delivery Rev. 46 2001 3 26
17. S. Kawakami, P. Opanasopit, M. Yokoyama, N. Chansri, T. Yamamoto, T. Okano, F. Yamashita, and M. Hashida Biodistribution characteristics of all-trans retinoic acid incorporated in liposomes and polymeric micelles following intravenous administration J. Pharm. Sci. 94 2005 2606 2615
18. G. Thurston, J.W. McLean, M. Rizen, P. Baluk, A. Haskell, T.J. Murphy, D. Hanahan, and D.M. McDonald Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice J. Clin. Invest. 101 1998 1401 1413
19. S. Krasnici, A. Werner, M.E. Eichhorn, M. Schmitt-Sody, S.A. Pahernik, B. Sauer, B. Schulze, M. Teifel, U. Michaelis, K. Naujoks, and M. Dellian Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels Int. J. Cancer 105 2003 561 567
20. W. Yeeprae, S. Kawakami, F. Yamashita, M. Hashida, Physicochemical and pharmacokinetic characteristics of cationic liposomes, Pharmazie (in press).
21. S. Kawakami, J. Wong, A. Sato, Y. Hattori, F. Yamashita, and M. Hashida Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice Biochim. Biophys. Acta 1524 2000 258 265
22. S. Kawakami, C. Munakata, S. Fumoto, F. Yamashita, and M. Hashida Novel galactosylated liposomes for hepatocyte-selective targeting of lipophilic drugs J. Pharm. Sci. 90 2001 105 113
23. S. Kawakami, K. Yamamura, T. Mukai, K. Nishida, J. Nakamura, T. Sakaeda, M. Nakashima, and H. Sasaki Sustained ocular delivery of tilisolol to rabbits after topical administration or intravitreal injection of lipophilic prodrug incorporated in liposomes J. Pharm. Pharmacol. 53 2001 1157 1161
24. M. Teshima, S. Kawakami, K. Nishida, J. Nakamura, T. Sakaeda, H. Terazono, T. Kitahara, M. Nakashima, and H. Sasaki Prednisolone retention in integrated liposomes by chemical approach and pharmaceutical approach J. Controlled Release 97 2004 211 218
25. S. Kawakami, F. Yamashita, M. Nishikawa, Y. Takakura, and M. Hashida Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes Biochem. Biophys. Res. Commun. 252 1998 78 83
26. P. Opanasopit, Y. Higuchi, S. Kawakami, F. Yamashita, M. Nishikawa, and M. Hashida Involvement of serum mannan binding proteins and mannose receptors in uptake of mannosylated liposomes by macrophages Biochim. Biophys. Acta 1511 2001 134 145
27. S. Kawakami, A. Sato, M. Nishikawa, F. Yamashita, and M. Hashida Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes Gene Ther. 7 2000 292 299
28. Y. Hattori, S. Kawakami, S. Suzuki, F. Yamashita, and M. Hashida Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice Biochem. Biophys. Res. Commun. 317 2004 992 999
29. C. Managit, S. Kawakami, F. Yamashita, and M. Hashida Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes J. Pharm. Sci. 94 2005 2266 2275
30. 2 inhibits alveolar epithelial wound repair in vitro by induction of apoptosis Am. J. Physiol.: Lung Cell. Mol. Physiol. 287 2004 L448 L453
31. F. Sakurai, R. Inoue, Y. Nishino, A. Okuda, O. Matsumoto, T. Taga, F. Yamashita, Y. Takakura, and M. Hashida Effect of DNA/liposome mixing ratio on the physicochemical characteristics, cellular uptake and intracellular trafficking of plasmid DNA/cationic liposome complexes and subsequent gene expression J. Controlled Release 66 2000 255 269
32. D. Lleres, J.M. Weibel, D. Heissler, G. Zuber, G. Duportail, and Y. Mely Dependence of the cellular internalization and transfection efficiency on the structure and physicochemical properties of cationic detergent/DNA/liposomes J. Gene Med. 6 2004 415 428
33. C.M. Wiethoff, J.G. Koe, G.S. Koe, and C.R. Middaugh Compositional effects of cationic lipid/DNA delivery systems on transgene expression in cell culture J. Pharm. Sci. 93 2004 108 123
34. K. Lotz, T. Kellner, M. Heitmann, I. Nazarenko, A. Noske, A. Malek, A. Gontarewicz, R. Schafer, and C. Sers Suppression of the TIG3 tumor suppressor gene in human ovarian carcinomas is mediated via mitogen-activated kinase-dependent and -independent mechanisms Int. J. Cancer 116 2005 894 902
35. S. Kawakami, F. Yamashita, K. Nishida, J. Nakamura, and M. Hashida Glycosylated cationic liposomes for cell-selective gene delivery Crit. Rev. Ther. Drug Carrier Syst. 19 2002 171 190
36. N. Zhu, D. Liggitt, Y. Liu, and R. Debs Systemic gene expression after intravenous DNA delivery into adult mice Science 261 1993 209 211
37. S. Li, and L. Huang In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes Gene Ther. 4 1997 891 900
38. S. Kawakami, S. Fumoto, M. Nishikawa, F. Yamashita, and M. Hashida In vivo gene delivery to the liver using novel galactosylated cationic liposomes Pharm. Res. 17 2000 306 313
39. S. Kawakami, A. Sato, M. Yamada, F. Yamashita, and M. Hashida The effect of lipid composition on receptor-mediated in vivo gene transfection using mannosylated cationic liposomes in mice STP Pharm. Sci. 11 2001 117 120
40. F. Sakurai, T. Terada, M. Maruyama, Y. Watanabe, F. Yamashita, Y. Takakura, and M. Hashida Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-β gene and poly I: poly C in a murine lung metastasis model Cancer Gene Ther. 10 2003 661 668